| Dr Serkan Mehmet Sahin, MD | |
|
1959 Ne Pacific St, Seattle, WA 98195-4880 | |
| (206) 543-6420 | |
| Not Available |
| Full Name | Dr Serkan Mehmet Sahin |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003234477 | NPI | - | NPPES |
| 1003234477 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD60742757 (Washington) | Secondary |
| 208M00000X | Hospitalist | MD60742757 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Washington Medical Ctr | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic inflammatory liver disease characterized by diffuse fibrosing inflammation of intra- and/or extrahepatic bile ducts, resulting in bile duct obliteration, biliary cirrhosis, and eventually hepatic failure. One of the most common symptoms at the time of presentation of PSC is mild to severe abdominal pain localized in the right upper quadrant. However, the mechanisms responsible for the abdominal pain in PSC are not fully understood.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.
Researchers have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with SARS-COV-2.
The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.
› Verified 9 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic inflammatory liver disease characterized by diffuse fibrosing inflammation of intra- and/or extrahepatic bile ducts, resulting in bile duct obliteration, biliary cirrhosis, and eventually hepatic failure. One of the most common symptoms at the time of presentation of PSC is mild to severe abdominal pain localized in the right upper quadrant. However, the mechanisms responsible for the abdominal pain in PSC are not fully understood.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.
Researchers have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with SARS-COV-2.
The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Serkan Mehmet Sahin, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Dr Serkan Mehmet Sahin, MD 1959 Ne Pacific St, Seattle, WA 98195-4880 Ph: (206) 543-6420 |
News Archive
Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic inflammatory liver disease characterized by diffuse fibrosing inflammation of intra- and/or extrahepatic bile ducts, resulting in bile duct obliteration, biliary cirrhosis, and eventually hepatic failure. One of the most common symptoms at the time of presentation of PSC is mild to severe abdominal pain localized in the right upper quadrant. However, the mechanisms responsible for the abdominal pain in PSC are not fully understood.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.
Researchers have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with SARS-COV-2.
The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.
› Verified 9 days ago
Dr. Tinsley Coble, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1550 N 115th Street, Northwest Hospital, Seattle, WA 98133 Phone: 206-368-1849 | |
Philip W Royal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Yordanos T Kahsai, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-624-1144 | |
Dr. James Papathanasiou, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 Broadway, Seattle, WA 98122 Phone: 206-329-1760 | |
Kristin T Tang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 747 Broadway, Seattle, WA 98122 Phone: 206-386-6000 Fax: 206-215-6364 | |
Srirama Josyula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
David J Horne, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-3241 |